MetLife/$MET
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About MetLife
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
Ticker
$MET
Sector
Primary listing
NYSE
Employees
45,000
Headquarters
Website
MetLife Metrics
BasicAdvanced
$50B
14.33
$5.30
-
$2.23
2.99%
Price and volume
Market cap
$50B
52-week high
$88.09
52-week low
$65.21
Average daily volume
3.1M
Dividend rate
$2.23
Financial strength
Current ratio
3.974
Quick ratio
3.74
Long term debt to equity
68.007
Total debt to equity
128.015
Interest coverage (TTM)
4.70%
Profitability
EBITDA (TTM)
5,678
Gross margin (TTM)
24.17%
Net profit margin (TTM)
5.34%
Operating margin (TTM)
6.91%
Effective tax rate (TTM)
21.58%
Revenue per employee (TTM)
$1,600,000
Management effectiveness
Return on assets (TTM)
0.44%
Return on equity (TTM)
12.80%
Valuation
Price to earnings (TTM)
14.331
Price to revenue (TTM)
0.719
Price to book
1.73
Price to tangible book (TTM)
2.53
Dividend yield (TTM)
2.93%
Forward dividend yield
2.99%
Growth
Revenue change (TTM)
0.82%
Earnings per share change (TTM)
7.68%
3-year revenue growth (CAGR)
-0.60%
10-year revenue growth (CAGR)
0.01%
3-year earnings per share growth (CAGR)
-2.63%
10-year earnings per share growth (CAGR)
0.27%
3-year dividend per share growth (CAGR)
-34.73%
10-year dividend per share growth (CAGR)
-9.32%
What the Analysts think about MetLife
Analyst ratings (Buy, Hold, Sell) for MetLife stock.
Bulls say / Bears say
First-quarter 2025 adjusted earnings rose 5% year-on-year to $1.35 billion, supported by a 16.5% gain in premiums and revenues and a 3% increase in net investment income, demonstrating strong top-line growth.
In April 2025, MetLife launched a $3 billion share buyback and agreed to reinsure $10 billion of U.S. retail variable annuity reserves with Talcott Financial Group, underlining robust capital generation and proactive risk management.
Net investment income rose 9% year-on-year to $5.7 billion in the second quarter of 2025, reflecting effective portfolio allocation and benefiting from the high-rate environment.
The second quarter of 2025 saw a 16% drop in MetLife’s adjusted profit, caused by lower premiums and less favorable underwriting margins in its life and non-medical health segments, pointing to volatility in core underwriting.
Adjusted premiums, fees, and other revenues declined 6% to $12.72 billion in Q2 2025, signaling revenue headwinds for key insurance products amid competitive and underwriting pressures.
MetLife’s share price underperformed the market, declining nearly 8% year-to-date through Q1 2025, while the S&P 500 fell 5.1%, illustrating ongoing investor skepticism despite operational resilience.
Data summarised monthly by Lightyear AI. Last updated on 2 Nov 2025.
MetLife Financial Performance
Revenues and expenses
MetLife Earnings Performance
Company profitability
MetLife News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for MetLife stock?
MetLife (MET) has a market cap of $50B as of November 07, 2025.
What is the P/E ratio for MetLife stock?
The price to earnings (P/E) ratio for MetLife (MET) stock is 14.33 as of November 07, 2025.
Does MetLife stock pay dividends?
Yes, the MetLife (MET) stock pays dividends to shareholders. As of November 07, 2025, the dividend rate is $2.225 and the yield is 2.99%. MetLife has a payout ratio of 0% on a trailing twelve-month basis.
When is the next MetLife dividend payment date?
The next MetLife (MET) dividend payment is scheduled for December 09, 2025.
What is the beta indicator for MetLife?
MetLife (MET) does not currently have a Beta indicator.